Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab

PURPOSE: The aim of this study is to report the short-term efficacy of aflibercept in the treatment of neovascular age-related macular degeneration (AMD) with associated retinal pigment epithelial detachment (PED) which is refractory or develops tachyphylaxis to bevacizumab and ranibizumab. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Patel, K H, Chow, C C, Rathod, R, Mieler, W F, Lim, J I, Ulanski, L J, Leiderman, Y I, Arun, V, Chau, F Y
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2013
Témata:
Case Series
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650278/
https://ncbi.nlm.nih.gov/pubmed/23558214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2013.31
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky